TY - JOUR
T1 - Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programs
AU - Hoppes, Emily
AU - Nwachukwu, Chukwuemeka
AU - Hennegan, Julie
AU - Blithe, Diana L.
AU - Cordova-Gomez, Amanda
AU - Critchley, Hilary
AU - Doncel, Gustavo F.
AU - Dorflinger, Laneta J.
AU - Haddad, Lisa B.
AU - Mackenzie, Amelia C.L.
AU - Maybin, Jacqueline A.
AU - Moley, Kelle
AU - Nanda, Kavita
AU - Sales Vieira, Carolina
AU - Vwalika, Bellington
AU - Kibira, Simon P.S.
AU - Mickler, Alexandria
AU - OlaOlorun, Funmilola M.
AU - Polis, Chelsea B.
AU - Sommer, Marni
AU - Williams, Katie M.
AU - Lathrop, Eva
AU - Mahajan, Tanya
AU - Rademacher, Kate H.
AU - Solomon, Marsden
AU - Wilson, Katrina
AU - Wilson, Lucy C.
AU - Rountree, Lillian
N1 - Funding Information:
We appreciate all those who contributed to the CIMC Technical Consultation in November 2020, especially those who participated in the discussion groups that were used to inform the first draft of the CIMC RLA. We acknowledge the contributions of the experts who provided feedback on the CIMC RLA during the community review process. Finally, we appreciate Dr. Barbara Sow of FHI 360 for reviewing the manuscript.
Publisher Copyright:
© 2022 Hoppes E et al.
PY - 2022
Y1 - 2022
N2 - Background: Contraceptive-induced menstrual changes (CIMCs) can affect family planning (FP) users' lives in both positive and negative ways, resulting in both opportunities and consequences. Despite this, and despite the important links between FP and menstrual health (MH), neither field adequately addresses CIMCs, including in research, product development, policies, and programs globally. Methods: In November 2020, a convening of both MH and FP experts reviewed the existing evidence on CIMCs and identified significant gaps in key areas. Results: These gaps led to the establishment of a CIMC Task Force in April 2021 and the development of the Global Research and Learning Agenda: Building Evidence on Contraceptive-Induced Menstrual Changes in Research, Product Development, Policies, and Programs Globally (the CIMC RLA) , which includes four research agendas for (1) measurement, (2) contraceptive research and development (R&D) and biomedical research, (3) social-behavioral and user preferences research, and (4) programmatic research. Conclusions: Guided by the CIMC RLA, researchers, product developers, health care providers, program implementers, advocates, policymakers, and funders are urged to conduct research and implement strategies to address the beneficial and negative effects of CIMCs and support the integration of FP and MH. CIMCs need to be addressed to improve the health and well-being of women, girls, and other people who menstruate and use contraceptives globally. Disclaimer : The views expressed in this article are those of the authors. Publication in Gates Open Research does not imply endorsement by the Gates Foundation.
AB - Background: Contraceptive-induced menstrual changes (CIMCs) can affect family planning (FP) users' lives in both positive and negative ways, resulting in both opportunities and consequences. Despite this, and despite the important links between FP and menstrual health (MH), neither field adequately addresses CIMCs, including in research, product development, policies, and programs globally. Methods: In November 2020, a convening of both MH and FP experts reviewed the existing evidence on CIMCs and identified significant gaps in key areas. Results: These gaps led to the establishment of a CIMC Task Force in April 2021 and the development of the Global Research and Learning Agenda: Building Evidence on Contraceptive-Induced Menstrual Changes in Research, Product Development, Policies, and Programs Globally (the CIMC RLA) , which includes four research agendas for (1) measurement, (2) contraceptive research and development (R&D) and biomedical research, (3) social-behavioral and user preferences research, and (4) programmatic research. Conclusions: Guided by the CIMC RLA, researchers, product developers, health care providers, program implementers, advocates, policymakers, and funders are urged to conduct research and implement strategies to address the beneficial and negative effects of CIMCs and support the integration of FP and MH. CIMCs need to be addressed to improve the health and well-being of women, girls, and other people who menstruate and use contraceptives globally. Disclaimer : The views expressed in this article are those of the authors. Publication in Gates Open Research does not imply endorsement by the Gates Foundation.
KW - CIMC
KW - Contraceptive
KW - Contraceptive-induced menstrual change
KW - Family planning
KW - Menstrual change
KW - Menstrual health
KW - Research agenda
KW - Research and learning agenda
UR - http://www.scopus.com/inward/record.url?scp=85131080115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131080115&partnerID=8YFLogxK
U2 - 10.12688/gatesopenres.13609.1
DO - 10.12688/gatesopenres.13609.1
M3 - Article
C2 - 35614964
AN - SCOPUS:85131080115
SN - 2572-4754
VL - 6
JO - Gates Open Research
JF - Gates Open Research
M1 - 49
ER -